Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E1 during heart transplantation

Anesthesia and Analgesia

Volumn 90, Issue 3, 2000, Pages 523-530

  Rajek, Angela ^a,b,d   Pernerstorfer, Thomas ^a   Kastner, Johannes ^a   Mares, Peter ^a   Grabenwöger, Martin ^a   Sessler, Daniel I ^a,b,c   Grubhofer, Georg ^a   Hiesmayr, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ETOMIDATE; FENTANYL; ISOPRENALINE; MIDAZOLAM; NITRIC OXIDE; NORADRENALIN; PANCURONIUM; PROSTAGLANDIN E1;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; FEMALE; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; INHALATION ANESTHESIA; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0034089302     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200003000-00005     Document Type: Article

References (34)

1. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1987;76:V52-5.
2. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993;126: 896-904.
3. Costard-Jackle A, Hill I, Schroeder JS, et al. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991;84:III329-37.
4. Kirklin JK, Naftel DC, Kirklin JW, et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988;7:331-6.
5. McCarthy JF, McCarthy PM, Massad MG, et al. Risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries? Arm Thorac Surg 1998;65:1574-9.
6. Kirsch M, Baufreton C, Naftel DC, et al. Pretransplantation risk factors for death after heart transplantation: the Henri Mondor. J Heart Lung Transplant 1998;17:268-77.
7. Bizouarn P, Treilhaud M, Portier D, et al. Right ventricular function early after total or standard orthotopic heart transplantation. Ann Thorac Surg 1994;57:183-7.
8. Chen EP, Bittner HB, Davis RD, et al. Right ventricular adaptation to increased afterload after orthotopic cardiac transplantation in the setting of recipient chronic pulmonary hypertension. Circulation 1997;96:II141-7.
9. Carteaux JP, Roux S, Siaghy M, et al. Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin. Eur J Cardiothorac Surg 1999;15:346-52.
10. Carrier M, Biaise G, Belisle S, et al. Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 1999;18:664-7.
11. Chen EP, Bittner HB, Davis RD, Jr, et al. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. Ann Thorac Surg 1997;63:1546-55.
12. Pascual JM, Fiorelli AI, Bellotti GM, et al. Prostacyclin in the management of pulmonary hypertension after heart transplantation. J Heart Transplant 1990;9:644-51.
13. Vincent JL, Carlier E, Pinsky MR, et al. Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg 1992;103:33-9.
14. Kieler-Jensen N, Milocco I, Ricksten SE. Pulmonary vasodilation after heart transplantation: a comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart Lung Transplant 1993;12:179-84.
15. Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47.
16. Gerlach H, Pappert D, Lewandowski K, et al. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993;19:443-9.
17. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
18. Rich GF, Murphy GD, Jr, Roos CM, et al. Inhaled nitric oxide: selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993;78:1028-35.
19. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328: 399-405.
20. Snow DJ, Gray SJ, Ghosh S, et al. Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth 1994;72:185-9.
21. Girard C, Lehot JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-3.
22. Salamonsen RF, Kaye D, Esmore DS. Inhalation of nitric oxide provides selective pulmonary vasodilatation, aiding mechanical cardiac assist with Thoratec left ventricular assist device. Anaesth Intensive Care 1994;22:209-10.
23. Auler Junior JO, Carmona MJ, Bocchi EA, et al. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 1996;15:443-50.
24. Williams TJ, Salamonsen RF, Snell G, et al. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 1995; 14:419-23.
25. Girard C, Durand PG, Vedrinne C, et al. Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth 1993;7:481-5.
26. Kieler-Jensen N, Lundin S, Ricksten SE. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant 1995;14:436-43.
27. Chen EP, Akhter SA, Bittner HB, et al. Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension. Ann Thorac Surg 1999;67:1053-8.
28. Bhatia SJ, Kirshenbaum JM, Shemin RJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 1987;76:819-26.
29. Prewitt RM, Ghignone M. Treatment of right ventricular dysfunction in acute respiratory failure. Crit Care Med 1983;11: 346-52.
30. Weber KT, Janicki JS, Shroff SG, et al. The right ventricle: physiologic and pathophysiologic considerations. Crit Care Med 1983;11:323-8.
31. Chen EP, Bittner HB, Tull F, et al. Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension. J Thorac Cardiovasc Surg 1997;113:849-57.
32. Naeije R, Lipski A, Abramowicz M, et al. Nature of pulmonary hypertension in congestive heart failure: effects of cardiac transplantation. Am J Respir Crit Care Med 1994;149:881-7.
33. Chau EM, Bailey KR, Mahoney DW, et al. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year. Circulation 1996;94: II267-72.
34. NIOSH recommendations for occupational safety and health standards 1988. MMWR Morb Mortal Wkly Rep 1988;37(Suppl 7):1-29.